The anticipated arrival of Sinovac antibodies from China on the 23rd of February is as yet open to question as the organization still can’t seem to submit four expected reports to the Food and Drug Administration. In view of this, FDA chief general Eric Domingo said the organization couldn’t yet settle on the use of Sinovac for crisis use approval …